Literature DB >> 20738990

The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009.

C C Blyth1, A Kelso, K A McPhie, V M Ratnamohan, M Catton, J D Druce, D W Smith, S H Williams, Q S Huang, L Lopez, B D Schoub, M Venter, D E Dwyer.   

Abstract

Data collected over winter 2009 by five World Health Organisation National Influenza Centres in the southern hemisphere were used to examine the circulation of pandemic and seasonal influenza A strains during the first pandemic wave in the southern hemisphere.There is compelling evidence that the pandemic influenza A(H1N1) 2009 virus significantly displaced seasonal influenza A(H1N1) and, to a lesser extent, A(H3N2) viruses circulating in the southern hemisphere. Complete replacement of seasonal influenza A strains, however, was not observed during the first pandemic wave.

Entities:  

Mesh:

Year:  2010        PMID: 20738990

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  11 in total

Review 1.  Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Authors:  Clayton A Wiley; Nitin Bhardwaj; Ted M Ross; Stephanie J Bissel
Journal:  Brain Pathol       Date:  2015-09       Impact factor: 6.508

2.  Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies.

Authors:  Dominic E Dwyer
Journal:  Vaccine       Date:  2011-07-22       Impact factor: 3.641

3.  Impact of influenza A(H1N1)pdm09 virus on circulation dynamics of seasonal influenza strains in Kenya.

Authors:  Janet Majanja; Rose N Njoroge; Rachel Achilla; Eyako K Wurapa; Meshack Wadegu; Silvanos Mukunzi; Josephat Mwangi; James Njiri; George Gachara; Wallace Bulimo
Journal:  Am J Trop Med Hyg       Date:  2013-03-04       Impact factor: 2.345

4.  Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.

Authors:  Gwendolyn L Gilbert; Michelle A Cretikos; Linda Hueston; George Doukas; Brian O'Toole; Dominic E Dwyer
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

5.  Were equatorial regions less affected by the 2009 influenza pandemic? The Brazilian experience.

Authors:  Cynthia Schuck-Paim; Cécile Viboud; Lone Simonsen; Mark A Miller; Fernanda E A Moura; Roberto M Fernandes; Marcia L Carvalho; Wladimir J Alonso
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

6.  A mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal model.

Authors:  James M McCaw; Nimalan Arinaminpathy; Aeron C Hurt; Jodie McVernon; Angela R McLean
Journal:  PLoS Comput Biol       Date:  2011-04-28       Impact factor: 4.475

7.  Chest computed tomography findings in severe influenza pneumonia occurring in neutropenic cancer patients.

Authors:  Rosana Souza Rodrigues; Edson Marchiori; Fernando A Bozza; Melissa Tassano Pitrowsky; Eduardo Velasco; Márcio Soares; Jorge I F Salluh
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

8.  Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses.

Authors:  Philippe F Simon; Marc-Antoine de La Vega; Éric Paradis; Emelissa Mendoza; Kevin M Coombs; Darwyn Kobasa; Catherine A A Beauchemin
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

9.  Trends of influenza infection in Suriname.

Authors:  Malti R Adhin; Meritha Grunberg; Mergiory Labadie-Bracho
Journal:  Influenza Other Respir Viruses       Date:  2012-11-08       Impact factor: 4.380

10.  Influenza-associated mortality in South Africa, 2009-2013: The importance of choices related to influenza infection proxies.

Authors:  Desmond Gul; Cheryl Cohen; Stefano Tempia; Anthony T Newall; David J Muscatello
Journal:  Influenza Other Respir Viruses       Date:  2017-12-02       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.